Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 21

1.

No mucosal atrophy and reduced inflammatory cells: active-controlled trial with yearlong fluticasone furoate nasal spray.

Fokkens WJ, Rinia B, van Drunen CM, Hellings PW, Hens G, Jansen A, Blom H, Wu W, Clements DS, Lee LA, Philpot EE.

Am J Rhinol Allergy. 2012 Jan-Feb;26(1):36-44. doi: 10.2500/ajra.2012.26.3675.

PMID:
22391079
2.

An integrated analysis of the efficacy of fluticasone furoate nasal spray on individual nasal and ocular symptoms of seasonal allergic rhinitis.

Maspero JF, Walters RD, Wu W, Philpot EE, Naclerio RM, Fokkens WJ.

Allergy Asthma Proc. 2010 Nov-Dec;31(6):483-92. doi: 10.2500/aap.2010.31.3397.

PMID:
21708060
3.

Is conjunctival allergen challenge a model of seasonal rhinoconjunctivitis?

Naclerio RM, Philpot EE.

Allergy Asthma Proc. 2009 Mar-Apr;30(2):212-3; author reply 213-4. doi: 10.2500/aap.2009.30.3220. No abstract available.

PMID:
19463211
4.

Fluticasone furoate nasal spray is more effective than fexofenadine for nighttime symptoms of seasonal allergy.

Andrews CP, Martin BG, Jacobs RL, Mohar DE, Diaz JD, Amar NJ, Kaiser HB, Vandewalker ML, Bernstein J, Toler WT, Prillaman BA, Dalal AA, Lee LA, Philpot EE.

Allergy Asthma Proc. 2009 Mar-Apr;30(2):128-38. doi: 10.2500/aap.2009.30.3204.

PMID:
19463203
5.

Weather/temperature-sensitive vasomotor rhinitis may be refractory to intranasal corticosteroid treatment.

Jacobs R, Lieberman P, Kent E, Silvey M, Locantore N, Philpot EE.

Allergy Asthma Proc. 2009 Mar-Apr;30(2):120-7. doi: 10.2500/aap.2009.30.3206.

PMID:
19463202
6.

Preferences of adult patients with allergic rhinitis for the sensory attributes of fluticasone furoate versus fluticasone propionate nasal sprays: a randomized, multicenter, double-blind, single-dose, crossover study.

Meltzer EO, Stahlman JE, Leflein J, Meltzer S, Lim J, Dalal AA, Prillaman BA, Philpot EE.

Clin Ther. 2008 Feb;30(2):271-9. doi: 10.1016/j.clinthera.2008.02.005.

PMID:
18343265
7.

Optimal dose selection of fluticasone furoate nasal spray for the treatment of seasonal allergic rhinitis in adults and adolescents.

Martin BG, Ratner PH, Hampel FC, Andrews CP, Toler T, Wu W, Faris MA, Philpot EE.

Allergy Asthma Proc. 2007 Mar-Apr;28(2):216-25.

PMID:
17479608
8.

Fluticasone furoate nasal spray: a single treatment option for the symptoms of seasonal allergic rhinitis.

Kaiser HB, Naclerio RM, Given J, Toler TN, Ellsworth A, Philpot EE.

J Allergy Clin Immunol. 2007 Jun;119(6):1430-7. Erratum in: J Allergy Clin Immunol. 2010 May;125(5):1068.

PMID:
17418384
9.
10.

Comparison of fluticasone propionate aqueous nasal spray and oral montelukast for the treatment of seasonal allergic rhinitis symptoms.

Martin BG, Andrews CP, van Bavel JH, Hampel FC, Klein KC, Prillaman BA, Faris MA, Philpot EE.

Ann Allergy Asthma Immunol. 2006 Jun;96(6):851-7.

PMID:
16802774
11.

Treatment with intranasal fluticasone propionate significantly improves ocular symptoms in patients with seasonal allergic rhinitis.

Bernstein DI, Levy AL, Hampel FC, Baidoo CA, Cook CK, Philpot EE, Rickard KA.

Clin Exp Allergy. 2004 Jun;34(6):952-7.

PMID:
15196285
12.

Concurrent use of intranasal and orally inhaled fluticasone propionate does not affect hypothalamic-pituitary-adrenal-axis function.

Sheth KK, Cook CK, Philpot EE, Prillaman BA, Witham LA, Faris MA, Klein KC, Rickard KA.

Allergy Asthma Proc. 2004 Mar-Apr;25(2):115-20.

PMID:
15176496
13.

Obstructive sleep apnea, nasal congestion, and snoring: their systemic effects and impact on quality of life.

Boyd EL, Philpot EE.

Allergy Asthma Proc. 2004 Jan-Feb;25(1):43-51. Review.

PMID:
15055562
14.

The efficacy of intranasal fluticasone propionate in the relief of ocular symptoms associated with seasonal allergic rhinitis.

DeWester J, Philpot EE, Westlund RE, Cook CK, Rickard KA.

Allergy Asthma Proc. 2003 Sep-Oct;24(5):331-7.

PMID:
14619333
15.

Fluticasone propionate aqueous nasal spray improves nasal symptoms of seasonal allergic rhinitis when used as needed (prn).

Dykewicz MS, Kaiser HB, Nathan RA, Goode-Sellers S, Cook CK, Witham LA, Philpot EE, Rickard K.

Ann Allergy Asthma Immunol. 2003 Jul;91(1):44-8.

PMID:
12877448
16.

Lack of effect of fluticasone propionate aqueous nasal spray on the hypothalamic-pituitary-adrenal axis in 2- and 3-year-old patients.

Galant SP, Melamed IR, Nayak AS, Blake KV, Prillaman BA, Reed KD, Cook CK, Philpot EE, Rickard KA.

Pediatrics. 2003 Jul;112(1 Pt 1):96-100.

PMID:
12837873
17.

Fluticasone propionate aqueous nasal spray provided significantly greater improvement in daytime and nighttime nasal symptoms of seasonal allergic rhinitis compared with montelukast.

Ratner PH, Howland WC 3rd, Arastu R, Philpot EE, Klein KC, Baidoo CA, Faris MA, Rickard KA.

Ann Allergy Asthma Immunol. 2003 May;90(5):536-42.

PMID:
12775135
18.

No growth suppression in children treated with the maximum recommended dose of fluticasone propionate aqueous nasal spray for one year.

Allen DB, Meltzer EO, Lemanske RF Jr, Philpot EE, Faris MA, Kral KM, Prillaman BA, Rickard KA.

Allergy Asthma Proc. 2002 Nov-Dec;23(6):407-13.

PMID:
12528607
19.

Relief of sinus pain and pressure with fluticasone propionate aqueous nasal spray: a placebo-controlled trial in patients with allergic rhinitis.

Ratner PH, Howland WC 3rd, Jacobs RL, Reed KD, Goode-Sellers ST, Prillaman BA, Philpot EE, Cook CK.

Allergy Asthma Proc. 2002 Jul-Aug;23(4):259-63.

PMID:
12221896
20.

Safety of second generation antihistamines.

Philpot EE.

Allergy Asthma Proc. 2000 Jan-Feb;21(1):15-20. Review.

PMID:
10748947
Items per page

Supplemental Content

Loading ...
Support Center